Source:http://linkedlifedata.com/resource/pubmed/id/12091216
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2002-7-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0002-953X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1246
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12091216-Adrenocorticotropic Hormone,
pubmed-meshheading:12091216-Adult,
pubmed-meshheading:12091216-Cushing Syndrome,
pubmed-meshheading:12091216-Enzyme Inhibitors,
pubmed-meshheading:12091216-Humans,
pubmed-meshheading:12091216-Hydrocortisone,
pubmed-meshheading:12091216-Male,
pubmed-meshheading:12091216-Metyrapone,
pubmed-meshheading:12091216-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Metyrapone for Cushing's syndrome.
|
pubmed:publicationType |
Letter,
Case Reports
|